risperidone has been researched along with Asperger Syndrome in 15 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Asperger Syndrome: A disorder beginning in childhood whose essential features are persistent impairment in reciprocal social communication and social interaction, and restricted, repetitive patterns of behavior, interests, or activities. These symptoms may limit or impair everyday functioning. (From DSM-5)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This case report describes two children who developed hyperammonemia together with frank manic behavior during treatment with a combination of valproic acid and risperidone." | 7.74 | Case report: valproic Acid and risperidone treatment leading to development of hyperammonemia and mania. ( Caplan, R; Carlson, T; Reynolds, CA, 2007) |
| "This case report describes two children who developed hyperammonemia together with frank manic behavior during treatment with a combination of valproic acid and risperidone." | 3.74 | Case report: valproic Acid and risperidone treatment leading to development of hyperammonemia and mania. ( Caplan, R; Carlson, T; Reynolds, CA, 2007) |
| "Autism spectrum disorder is characterized by difficulty with social communication and restricted, repetitive patterns of behavior, interest, or activities." | 2.53 | Autism Spectrum Disorder: Primary Care Principles. ( Sanchack, KE; Thomas, CA, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (66.67) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmidt, SJ | 1 |
| Behar, A | 1 |
| Schultze-Lutter, F | 1 |
| Frank, GK | 1 |
| Bloomfield, K | 1 |
| Pulliam, E | 1 |
| Schultz, E | 1 |
| Ward, WL | 1 |
| Sanchack, KE | 1 |
| Thomas, CA | 1 |
| Weber, K | 1 |
| Yui, K | 1 |
| Murphy, D | 1 |
| Monge Galindo, L | 1 |
| Escosa García, L | 1 |
| García Sánchez, N | 1 |
| Ruiz-Lázaro, PM | 1 |
| Scahill, L | 2 |
| McDougle, CJ | 2 |
| Aman, MG | 2 |
| Johnson, C | 1 |
| Handen, B | 1 |
| Bearss, K | 1 |
| Dziura, J | 1 |
| Butter, E | 1 |
| Swiezy, NG | 1 |
| Arnold, LE | 2 |
| Stigler, KA | 1 |
| Sukhodolsky, DD | 1 |
| Lecavalier, L | 2 |
| Pozdol, SL | 1 |
| Nikolov, R | 1 |
| Hollway, JA | 1 |
| Korzekwa, P | 1 |
| Gavaletz, A | 1 |
| Kohn, AE | 1 |
| Koenig, K | 1 |
| Grinnon, S | 1 |
| Mulick, JA | 1 |
| Yu, S | 1 |
| Vitiello, B | 2 |
| Mukaddes, NM | 1 |
| Topcu, Z | 1 |
| Rausch, JL | 1 |
| Sirota, EL | 1 |
| Londino, DL | 1 |
| Johnson, ME | 1 |
| Carr, BM | 1 |
| Bhatia, R | 1 |
| Miller, S | 1 |
| Carlson, T | 1 |
| Reynolds, CA | 1 |
| Caplan, R | 1 |
| Nagao, K | 1 |
| Carr, JE | 1 |
| LeBlanc, LA | 1 |
| Sukhodolsky, DG | 1 |
| Gadow, KD | 1 |
| McCracken, JT | 1 |
| Tierney, E | 1 |
| Williams White, S | 1 |
| Frazier, JA | 1 |
| Doyle, R | 1 |
| Chiu, S | 1 |
| Coyle, JT | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of PLAY Project Intervention Program on Children With Autism Spectrum Disorder: A Multi-center, Randomized Control Study in China[NCT05531669] | 200 participants (Anticipated) | Interventional | 2022-08-01 | Recruiting | |||
| Risperidone and Behavioral Therapy in Treatment of Children and Adolescents With Autistic Disorder[NCT00080145] | 124 participants (Actual) | Interventional | 2004-02-29 | Completed | |||
| Methylphenidate for Hyperactivity and Impulsiveness in Children and Adolescents With Pervasive Developmental Disorders[NCT00025779] | 60 participants | Interventional | 2001-10-31 | Completed | |||
| Neural Mechanisms of CBT for Anxiety in Children With Autism: Randomized Controlled Trial[NCT02725619] | 70 participants (Actual) | Interventional | 2016-04-30 | Completed | |||
| Neural Mechanisms of Cognitive-Behavioral Therapy for Anxiety in Children With Autism Spectrum Disorder: A Pilot Study[NCT02225808] | 10 participants (Actual) | Interventional | 2014-08-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for risperidone and Asperger Syndrome
| Article | Year |
|---|---|
Autism Spectrum Disorder: Primary Care Principles.
Topics: Antipsychotic Agents; Aripiprazole; Asperger Syndrome; Autism Spectrum Disorder; Autistic Disorder; | 2016 |
Asperger's syndrome: from hiding to thriving.
Topics: Adaptation, Psychological; Asperger Syndrome; Benzodiazepines; Causality; Central Nervous System Dep | 2008 |
[Asperger syndrome in adolescence: The problem and appropriate treatment].
Topics: Adolescent; Adult; Antipsychotic Agents; Asperger Syndrome; Cognitive Behavioral Therapy; Delusions; | 2007 |
Autism spectrum disorders in early childhood: an overview for practicing physicians.
Topics: Asperger Syndrome; Autistic Disorder; Behavior Therapy; Behavioral Medicine; Child; Child Developmen | 2007 |
2 trials available for risperidone and Asperger Syndrome
| Article | Year |
|---|---|
Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems.
Topics: Adaptation, Psychological; Adolescent; Antipsychotic Agents; Asperger Syndrome; Autistic Disorder; C | 2012 |
Open-label risperidone for Asperger's disorder: negative symptom spectrum response.
Topics: Adolescent; Antipsychotic Agents; Asperger Syndrome; Basal Ganglia Diseases; Child; Diagnostic and S | 2005 |
9 other studies available for risperidone and Asperger Syndrome
| Article | Year |
|---|---|
[Asperger Syndrome and/or Clinical High Risk of Psychosis? A Differential Diagnostic Challenge].
Topics: Adolescent; Asperger Syndrome; Child; Child, Preschool; Cognitive Behavioral Therapy; Combined Modal | 2018 |
An 11-year-old boy with Asperger's disorder presenting with aggression.
Topics: Aggression; Antipsychotic Agents; Asperger Syndrome; Behavior Control; Child; Child Behavior; Dose-R | 2013 |
Russian Adoption: A Case Study With Mixed Clinical Presentation.
Topics: Adoption; Amphetamines; Antipsychotic Agents; Asperger Syndrome; Central Nervous System Stimulants; | 2015 |
[Cerebral physiopathology and treatment of Asperger disorder].
Topics: Adolescent; Adult; Asperger Syndrome; Brain; Child; Child, Preschool; Fatty Acids, Unsaturated; Fema | 2008 |
[Hyperprolactinemia in a child diagnosed with Asperger syndrome and hyperkinetic disorder treated with risperidone].
Topics: Antipsychotic Agents; Asperger Syndrome; Attention Deficit Disorder with Hyperactivity; Child, Presc | 2009 |
Letter to the editors.
Topics: Adolescent; Antipsychotic Agents; Asperger Syndrome; Comorbidity; Humans; Male; Risperidone; Schizop | 2005 |
Case report: valproic Acid and risperidone treatment leading to development of hyperammonemia and mania.
Topics: Antipsychotic Agents; Asperger Syndrome; Attention Deficit Disorder with Hyperactivity; Bipolar Diso | 2007 |
Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
Topics: Adolescent; Aggression; Antipsychotic Agents; Anxiety; Asperger Syndrome; Attention Deficit Disorder | 2008 |
Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
Topics: Adolescent; Aggression; Antipsychotic Agents; Anxiety; Asperger Syndrome; Attention Deficit Disorder | 2008 |
Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
Topics: Adolescent; Aggression; Antipsychotic Agents; Anxiety; Asperger Syndrome; Attention Deficit Disorder | 2008 |
Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
Topics: Adolescent; Aggression; Antipsychotic Agents; Anxiety; Asperger Syndrome; Attention Deficit Disorder | 2008 |
Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
Topics: Adolescent; Aggression; Antipsychotic Agents; Anxiety; Asperger Syndrome; Attention Deficit Disorder | 2008 |
Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
Topics: Adolescent; Aggression; Antipsychotic Agents; Anxiety; Asperger Syndrome; Attention Deficit Disorder | 2008 |
Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
Topics: Adolescent; Aggression; Antipsychotic Agents; Anxiety; Asperger Syndrome; Attention Deficit Disorder | 2008 |
Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
Topics: Adolescent; Aggression; Antipsychotic Agents; Anxiety; Asperger Syndrome; Attention Deficit Disorder | 2008 |
Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning.
Topics: Adolescent; Aggression; Antipsychotic Agents; Anxiety; Asperger Syndrome; Attention Deficit Disorder | 2008 |
Treating a child with Asperger's disorder and comorbid bipolar disorder.
Topics: Adolescent; Asperger Syndrome; Bipolar Disorder; Comorbidity; Drug Therapy, Combination; Follow-Up S | 2002 |